ArrowMark Partners is an investment management firm that offers a range of investment strategies across equities and fixed income for institutional investors, financial intermediaries, and high-net-worth individuals. The firm focuses on providing specialized investment solutions with an emphasis on fundamental research and a disciplined investment process.

ArrowMark Partners

ArrowMark Commercial Real Estate Finance Partners

ArrowMark Partners is an employee-owned asset management firm founded in 2007. Today, ArrowMark manages $21.4 billion* in assets on behalf of a broad array of institutional clients and professional asset allocators across alternative credit and capacity-constrained equity strategies, as well as through the management of broadly syndicated and middle-market CLO Funds. Our unique approach, based on the team’s collective experience navigating market cycles, provides extensive insights across the capital structure and a skilled understanding of how to manage complex risk/reward tradeoffs through fundamental research.*As of 9/30/2023. CRE AUM includes commercial mortgage loans that ArrowMark or its affiliate has originated and/or currently manages on behalf of insurance companies and other institutional investors.

Xometry

Ginkgo Bioworks

Shift

NexImmune

Orchard Therapeutics

Latch

Lyra Therapeutics

MarkLogic

Syndax Pharmaceuticals

Starry

Taysha Gene Therapies

4D Molecular Therapeutics

Absci

Invivyd

Amunix

ArcherDX

Moderna

Twilio

ORIC Pharmaceuticals

Precision BioSciences

COM:ARROWMARKPARTNERS

ArrowMark Partners

locale

market

industry

website

crunchbase

linkedin

invested in

Metrics